🔎 Trials Near Me

Home › Melanoma › Missouri

Studi clinici su Melanoma nello stato di Missouri

23 studi su Melanoma cercano partecipanti presso sedi nello stato di Missouri.

Città nello stato di Missouri

Testo ufficiale dello studio (inglese)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Washington University Medicine, St Louis
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • e altri 21
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • e altri 4
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • VA St. Louis Healthcare System, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy South, St Louis
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06246916

Pan-tumor MRD Study

  • Cox Health, Springfield
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • University of Kansas Cancer Center - Briarcliff, Kansas City
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit
In reclutamentoFase 3
Età 75 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

  • Washington University School of Medicine, St Louis
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06529822

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Washington University, St Louis
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT05267626

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • e altri 19
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT04511013

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • e altri 2
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 ago 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Washington University School of Medicine, St Louis
In reclutamentoFase 1/2
12 Months – 30 Years · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

  • University of Missouri Children's Hospital, Columbia
  • Children's Mercy Hospitals and Clinics, Kansas City
  • Cardinal Glennon Children's Medical Center, St Louis
  • e altri 2
In reclutamentoStudio osservazionale
Fino a 25 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, St Louis
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT07115043

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT06910657

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • e altri 3
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - SPG, Springfield
  • Mercy Hospital - South, St Louis
  • Mercy Hospital -STL, St Louis
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT07327489

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

  • Saint Louis University Hospital, St Louis
  • Washington University of St. Louis, St Louis
In reclutamentoFase 1/2
Età da 18 a 90 · Tutti i sessi · Aggiornato il 10 giu 2026 · NCT05655312

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Saint Louis Cancer and Breast Institute-Ballwin, Ballwin
  • Parkland Health Center - Farmington, Farmington
  • e altri 16
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

  • Washington University School of Medicine, St Louis
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 feb 2026 · NCT05549297

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

  • Washington University School of Medicine, St Louis
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 feb 2026 · NCT04354064

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Kansas City
  • Massive Bio SYNERGY-AI site, St Louis
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Siteman Cancer Centre, Barnes Jewish West County, Creve Coeur
  • University of Kansas Cancer Center, Kansas City
  • Cox South Hospital, Springfield
  • e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 nov 2024 · NCT03860883

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.